Thu. Sep 10, 2020 2:00 PM – 3:00 PM EDT


Real-world data (RWD) is playing an increasing role in health care decisions, especially with autoimmune diseases where diagnosis can be difficult and there is no cure. Despite the promises of RWD to improve our understanding of the natural history of these diseases and to better demonstrate treatment effectiveness, challenges with RWD analyses exist and can provide significant roadblocks.

Join OM1’s Chief Medical Officer Dr. Gary Curhan and VP of Biostatistics Dr. Zhaohui Zhou as they explore some of the challenges and how to overcome them, including:

  • Why selection bias exists and how it can be corrected
  • Common mistakes in handling missing data and how to avoid making them
  • Considerations in selecting covariates

**Please be advised this webinar is intended primarily for medical device and diagnostic companies. Due to the proprietary nature of the content, vendors and consultants’ registration approval is at the discretion of OM1.